As plasma protein therapies evolve to satisfy the world’s demand, the volume and costs of the therapies produced is dictated by which of the therapies is in highest demand.
Today’s consumers rely on Internet research to self-diagnose everything from headaches to heart disease, and it’s a trend that has irrevocably altered the dynamic of traditional doctor-patient relations.
Unpredictable fluctuation in supply and demand, combined with the current reimbursement model, is the root of the problem of affordableIG treatment.